Form 8-K - Current report:
SEC Accession No. 0001193125-12-343793
Filing Date
2012-08-08
Accepted
2012-08-08 15:16:33
Documents
2
Period of Report
2012-08-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d392744d8k.htm 8-K 20180
2 AMENDMENT DEED d392744dex21.htm EX-2.1 21364
  Complete submission text file 0001193125-12-343793.txt   42947
Mailing Address 12270 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 12270 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 121016660
SIC: 2836 Biological Products, (No Diagnostic Substances)